
Transition from Waivers and Flexibilities – Industry News, February 2023
Transition from Waivers and Flexibilities; Medicare Part B Drug Inflation Rebates; Radiologists, Physician Groups Oppose Prior Authorization Policies
Transition from Waivers and Flexibilities; Medicare Part B Drug Inflation Rebates; Radiologists, Physician Groups Oppose Prior Authorization Policies
Dates for Medicare Drug Price Negotiation Program; Concerns Raised Over Newly Approved Prostate Treatment; Public Health Emergency Slated to End; Payment Processing Issue Identified
CAR T-cell NCD Updates; ASTRO, ACR Express Disappointment in Omnibus; 340B Drug Program Modifiers; Drug Waste Explained
CMS Releases 2023 Final Rules; ACR Releases Updated Fluoro Dose Index; CPT® 2023 Updates; Noridian Notifies of Reimbursement Issue
Avoid Rejected Claims for HCPCS Invoices; New US NCCI Edits; Federal Judge Halts 340B Reimbursement Cuts; PHE Extended Through January 2023
AMA Releases CPT® 2023 Code Set; ACR Changes Requirements, Allows Non-Physician Practitioners to Supervise Contrast Studies
CMS’ Roadmap for the End of the PHE; October HCPCS Update Includes New Codes for PET Radiopharmaceuticals, Cancer Treatment Drugs
CMS Releases CY 2023 MPFS Proposed Rule; CMS Releases CY 2023 HOPPS/ASC Payment Systems Proposed Rule
New Model for Cancer Care Announced; MAC Probe Results Provide Denial Insights; U.S. Supreme Court Rules 340B Cuts Unlawful
Sign up for the RCCS newsletter!
Subscribe to our mailing list for the latest industry news, events, and more!
© 2023 Revenue Cycle Coding Strategies. All rights reserved.